Pauline Dürr

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Clinical Practice

Palliative Care

Placebo Controlled

Top Venues

JCO oncology practice

Journal of clinical medicine

Clinical pharmacology and therapeutics

Healthcare (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Lisa Cuba, Pauline Dürr, Frank Dörje, Martin F Fromm, Katja Schlichtig
From the Randomized AMBORA Trial to Clinical Practice: Comparison of Medication Errors in Oral Antitumor Therapy. Clinical pharmacology and therapeutics 116 (1) (2024)
Lisa Cuba, Pauline Dürr, Katja Gessner, Babette Häcker, Rainer Fietkau, Jürgen Siebler, Marianne Pavel, Markus F Neurath, Carola Berking, Bernd Wullich, Valeska Brückl, Matthias W Beckmann, Martin F Fromm, Frank Dörje
A Hybrid Type III Effectiveness-Implementation Trial to Optimize Medication Safety With Oral Antitumor Therapy in Real-World: The AMBORA Competence and Consultation Center. JCO oncology practice (2024)
Lisa Cuba, Pauline Dürr, Frank Dörje, Martin F Fromm, Katja Schlichtig
From the Randomized AMBORA Trial to Clinical Practice: Comparison of Medication Errors in Oral Antitumor Therapy. Clinical pharmacology and therapeutics (2024)
Lisa Cuba, Pauline Dürr, Katja Gessner, Babette Häcker, Rainer Fietkau, Jürgen Siebler, Marianne Pavel, Markus F Neurath, Carola Berking, Bernd Wullich, Valeska Brückl, Matthias W Beckmann, Martin F Fromm, Frank Dörje
A Hybrid Type III Effectiveness-Implementation Trial to Optimize Medication Safety With Oral Antitumor Therapy in Real-World: The AMBORA Competence and Consultation Center. JCO oncology practice (2024)
Lisa Cuba, Katja Schlichtig, Pauline Dürr, Elisabeth C Inwald, Martin F Fromm, Frank Dörje
Optimizing Medication Safety with Oral Antitumor Therapy: A Methodological Approach for the Real-World Implementation of the AMBORA Competence and Consultation Center. Healthcare (Basel, Switzerland) 11 (11) (2023)
Katja Schlichtig, Lisa Cuba, Pauline Dürr, Laura Bellut, Norbert Meidenbauer, Frank Kunath, Peter J Goebell, Andreas Mackensen, Frank Dörje, Martin F Fromm, Bernd Wullich
New Oral Antitumor Drugs and Medication Safety in Uro-Oncology: Implications for Clinical Practice Based on a Subgroup Analysis of the AMBORA Trial. Journal of clinical medicine 11 (15) (2022)
Pauline Dürr, Florian Meier, Katja Schlichtig, Anja Schramm, Lukas Schötz, Martin F Fromm, Frank Dörje
Characteristics and Cost of Unscheduled Hospitalizations in Patients Treated with New Oral Anticancer Drugs in Germany: Evidence from the Randomized AMBORA Trial. Journal of clinical medicine 11 (21) (2022)
Wahram Andrikyan, Melanie I Then, Karl-Günter Gaßmann, Thomas Tümena, Pauline Dürr, Martin F Fromm, Renke Maas
Use of medication data alone to identify diagnoses and related contraindications: Application of algorithms to close a common documentation gap. British journal of clinical pharmacology 88 (12) (2022)
Niklas Kehl, Katja Schlichtig, Pauline Dürr, Laura Bellut, Frank Dörje, Rainer Fietkau, Marianne Pavel, Andreas Mackensen, Bernd Wullich, Renke Maas, Martin F Fromm, Arne Gessner, Regina Verena Taudte
An Easily Expandable Multi-Drug LC-MS Assay for the Simultaneous Quantification of 57 Oral Antitumor Drugs in Human Plasma. Cancers 13 (24) (2021)